Articles tagged with Heart Failure
Researchers identified five subtypes of heart failure using machine learning, including early onset and atrial fibrillation related. These subtypes have different mortality risks, with some patients at higher risk of dying within a year after diagnosis.
Women with short or long menstrual cycles are at increased risk of cardiovascular disease events such as heart attack or AFib. The study analyzed data from over 58,000 women and found that irregular menstrual cycle length was associated with higher risks of CVD, independent of other factors.
The PARAGLIDE-HF trial found that sacubitril/valsartan significantly reduces plasma NT-proBNP levels compared to valsartan alone in patients with an ejection fraction above 40%. The study also showed a larger treatment effect in those with EF ≤60%, suggesting potential benefits for this population.
The MONITOR-HF trial found that remote pulmonary artery pressure monitoring significantly improved quality of life by 7.1 points at 12 months, with a 44% reduction in heart failure hospitalizations or urgent visits during follow-up. The procedure was safe and reliable, with a high level of adherence to guideline-directed medical therapy.
The new guideline provides guidance on the use of cardiac resynchronization therapy and conduction system pacing in patients with indications for pacemakers or heart failure. The authors emphasize the importance of shared decision-making between providers and patients, and highlight areas for future research.
A study funded by the National Institutes of Health found that vigorous exercise is safe for people with hypertrophic cardiomyopathy, a rare inherited disorder affecting the heart muscle. The research, published in JAMA Cardiology, suggests that restrictions on exercise may be unnecessary for individuals with HCM.
A new Northwestern Medicine study found young adult cancer survivors (18-39 years old) are 2.6 times more likely to develop heart failure when treated with anthracyclines. The incidence is highest among leukemia and other specific cancer types.
The study used magnetic resonance imaging (MRI) to measure acute pressure changes inside the heart, discovering that pressure increases when patients receive a specific medication called adenosine. This technology can help doctors better diagnose and monitor patients with heart disease and heart failure.
A new genetic mutation has been identified as the cause of infantile dilated cardiomyopathy, a common cause of heart failure in children. The mutation disrupts centrosome structure, leading to disorganized muscle cells and poor heart function.
Researchers found that solriamfetol, armodafinil–modafinil, and pitolisant reduce excessive daytime sleepiness in patients with obstructive sleep apnea already using conventional therapy. However, patients may be more likely to discontinue the use of these medications due to adverse events including headache, anxiety, and insomnia.
A retrospective cohort study of U.S. veterans found that adding a GLP1 receptor agonist to diabetes treatment reduced the risk of major adverse cardiovascular events and heart failure hospitalization by about 20% compared to DPP4 inhibitors. The study's findings will aid clinicians in choosing a diabetes drug regimen for older patients.
Dr. Miaomiao Zhang's research aims to automate late mechanical activation detection from cardiac magnetic resonance images using machine learning and AI techniques. This could lead to more accurate placement of CRT electrodes and improved patient outcomes.
Researchers have observed beta-arrestin molecules directly controlling receptor-mediated signals in living cells using advanced microscopy. The study reveals a new mechanism of how these proteins interact with receptors on the plasma membrane, enabling efficient control of signal flow and desensitization.
Researchers successfully performed the first in-utero surgery to repair a potentially deadly developmental condition called vein of Galen malformation. The procedure involved treating an aggressive vascular malformation before birth, resulting in improved cardiac output and no signs of negative effects on the brain after birth.
A study published in PLOS ONE found that long-term exposure to fine particulate matter (PM2.5) air pollution is associated with an increase in hospital procedures for heart failure patients, including stress tests and prothrombin time tests. This suggests that high PM2.5 exposure may lead to increased cardiovascular morbidity and promp...
Researchers at West Virginia University found that bariatric surgery significantly reduces the risk of major cardiovascular events and death in patients with NAFLD. The study included 9,374 adult patients with NAFLD and obesity, who underwent either Roux-en-Y gastric bypass or sleeve gastrectomy.
A large study found no difference in cardiovascular outcomes between patients taking beta blockers and those who didn't, after a year of hospital discharge. The researchers suggest reevaluating the value of long-term beta blocker therapy in low-risk heart attack patients with normal functioning hearts.
The program guide for TVT 2023 showcases over 200 world-renowned faculty experts, with a focus on clinical decision-making and strategies for treating valvular heart disease. The summit highlights the latest advances in transcatheter valve therapy and nonsurgical procedures.
A study found that young women are more likely to experience adverse outcomes and rehospitalization after a heart attack, with non-cardiac hospitalizations showing the most significant disparity. Researchers highlight the need for public awareness and sex-specific post-heart attack care.
A study supported by the National Institutes of Health found that younger women are nearly twice as likely to be rehospitalized after a heart attack as men. The disparity is largely due to higher rates of risk factors such as obesity and depression among women, which contribute to more adverse outcomes.
Researchers at UCL have identified proteins in the blood associated with an increased risk of developing heart diseases, including heart failure. The findings could lead to more refined cancer treatments that minimize cardiotoxicity and improve survival rates.
Researchers have developed a non-invasive technique using laser speckle imaging to visualize microvasculature in donor hearts and detect abnormal blood flow. The method enables precise visualization of blood circulation, potentially identifying hearts suitable for transplantation.
A new study found that quality of heart failure care is equitable for 11 of 14 evidence-based clinical care measures, with no disparities in care between Black and white patients. However, the study highlights areas for improvement, including gaps in care quality and social determinants of health.
A new meta-analysis finds that Black patients are 71% more likely to experience heart damage following chemotherapy treatment. The study highlights the need for further research into underlying factors contributing to these disparities to reduce cardiovascular risk associated with chemotherapy.
A novel treatment approach called balloon pulmonary angioplasty has been shown to be effective in treating chronic blood clots in lung arteries. The procedure improves exercise capacity and quality of life, with some patients able to stop medications altogether. Refinements in technique have improved the procedure's safety and efficacy.
Researchers at TUM have developed a method to create mini-hearts in Petri dishes using stem cells. The resulting organoids mimic the earliest stages of human heart development and can be used to investigate congenital heart defects, potentially leading to new treatment methods.
A new study published in The European Heart Journal – Digital Health found that smart watch data can predict a higher risk of developing heart failure and irregular heart rhythms. Researchers used machine learning to analyze ECG recordings from wearable devices and identified extra beats as indicators of increased cardiovascular risk.
A randomized clinical trial found that a video-based decision support tool increased patient knowledge, but not assent, to ICD implantation among Black patients. The study also highlighted the complexity of aversion to cardiac procedures in Black communities, emphasizing the need for further research on social determinants of health.
Researchers at Temple University and Johns Hopkins University found that brain-derived neurotrophic factor (BDNF) loss underlies post-myocardial infarction heart failure. BDNF levels can be replenished therapeutically, abolishing damage to heart tissue and enabling recovery.
Researchers from the Smidt Heart Institute found that individuals with spherical hearts are 31% more likely to develop atrial fibrillation and 24% more likely to develop cardiomyopathy. The study identified four genes associated with cardiomyopathy and a greater risk of developing atrial fibrillation.
A novel drug, AF-130, has been shown to improve heart function and prevent sleep apnoea in heart failure patients. This breakthrough could lead to improved life expectancy and wellness for nearly 200,000 people in New Zealand affected by heart disease.
Supervised exercise training is safe and may improve exercise capacity and quality of life for people with heart failure with preserved ejection fraction (HFpEF). Exercise therapy has been shown to be more effective in improving quality of life compared to medications for this condition.
A new study published in the European Heart Journal shows that using waist-to-height ratio instead of BMI provides a clearer picture of patient outcomes in heart failure. The researchers found that greater adiposity is associated with worse outcomes, including high rates of hospitalization and reduced health-related quality of life.
A clinical study published in the European Heart Journal found that ghrelin increases the heart's pump capacity in patients with heart failure, improving cardiac output by 28% after two hours of treatment. The treatment also showed a 10% higher pump capacity at follow-up.
A University of Ottawa study found that almost two-thirds of Canadians with stroke experience disturbed sleep, and those affected are up to 7 times more likely to report multiple sleep problems. The study highlights the need for better awareness and guidance on managing sleep disorders in stroke patients.
Researchers at University of Technology Sydney have successfully created personalized 'bio-inks' from patients' own stem cells, which are then used to 3D-print cardiac tissues to repair areas of dead tissue. This technology shows promise in treating heart failure and may reduce the need for expensive and traumatic heart transplants.
Researchers at Brigham and Boston Medical Center found associations between kidney damage and increased risk of heart disease and death. The study analyzed kidney tissue from 597 adults with chronic kidney disease, linking specific lesions to cardiovascular events.
A University of Chicago study found that older adults living near fracking sites in Pennsylvania had higher rates of cardiovascular disease hospitalizations compared to those in nearby New York state. The study linked exposure to air and water pollution from fracking activity to increased health outcomes.
A virtual care team consisting of physicians and pharmacists improved the adoption of life-saving therapies in patients with heart failure, leading to increased use of evidence-based treatments and better patient outcomes. The strategy was safe and effective, with comparable length of stay and safety events between the groups.
A new study shows that transcatheter mitral valve repair significantly reduces hospitalizations by almost 50 percent and death by nearly 30 percent in heart failure patients with severe mitral regurgitation. The procedure, using Abbott's MitraClip system, improves symptoms, reduces hospitalizations, and leads to longer survival.
A new study found that walking an additional 500 steps per day was associated with a 14% lower risk of heart disease, stroke or heart failure. This benefit is significant for older adults, as most studies have focused on early-to-midlife adults.
A new study published in the Journal of the American Heart Association found that participating in home-based cardiac rehabilitation was associated with a 36% lower likelihood of death from heart-related complications among US military veterans within four years. The study analyzed data from 1,120 veterans who enrolled in a 12-week hom...
Researchers at University Hospitals Cleveland Medical Center discovered that S-nitrosohemoglobin senses areas with insufficient oxygen and restores blood flow for oxygenation. This breakthrough opens up a new line of drug development to correct poor tissue oxygenation, including peripheral artery disease and sickle cell disease.
Researchers at Rutgers University used artificial intelligence to analyze genes associated with cardiovascular disease, identifying key factors such as age, gender, and race. The study aims to accelerate early diagnosis and treatment of conditions like atrial fibrillation and heart failure.
A new cell therapy has demonstrated significant benefits in improving the heart's pumping ability and reducing the risk of cardiovascular death, heart attack, or stroke in patients with chronic heart failure. The therapy, using mesenchymal precursor cells (MPCs), also showed a strong signal in reducing inflammation and improving microv...
Researchers estimate that up to 2% of adults in these regions have heart failure, with significant health risks and costs. The study analyzed digital health records from 11 countries and found that preventive treatment should focus on stopping further worsening of heart failure and kidney function.
Health systems nationwide are committing to better heart failure patient care through the American Heart Association's IMPLEMENT-HF initiative, which aims to bridge gaps in care and improve outcomes. The program uses established data collection approaches to develop new standards for heart failure patient management.
A multinational study of over 600,000 heart failure patients found that the disease is relatively fatal, with an average annual death rate of 13%, and results in high healthcare costs. The study also identified new treatment opportunities for heart failure with preserved left ventricular function.
Researchers at The Hospital for Sick Children have discovered that dysregulation of energy production is an early sign of heart failure. They found that lysine demethylase 8 (Kdm8) helps maintain balanced energy use, but its suppression leads to changes in metabolism.
A new study found that a medication previously used to treat seizures can reprogram donor hearts to boost the production of beneficial enzymes, increasing storage time and improving post-transplant function. This technology could lead to a paradigm shift in extending heart storage and reducing primary graft dysfunction.
Researchers found that pacing patients at faster heart rates improved quality of life, physical activity, and reduced atrial fibrillation. This new treatment approach shows promise in treating heart failure with a stiff heart muscle.
A new study published in the Journal of the American Heart Association found that people hospitalized for sepsis are at a higher risk of heart failure and rehospitalization within 12 years. The researchers analyzed data from over 2 million adults who survived non-surgical hospitalizations between 2009 and 2019.
A large study published in JACC: Heart Failure found that social isolation and loneliness are associated with higher rates of heart failure. However, feelings of loneliness were found to be a stronger predictor of heart failure risk than objective social isolation. The study suggests that effective tools for screening social isolation ...
A study published in JAMA Cardiology found that rurality is associated with a higher risk of heart failure among predominantly low-income individuals in the southeastern United States. The inequity highlights the need for targeted primary prevention efforts for rural populations.
A large NIH-supported study found that adults living in rural areas have a 19% higher risk of developing heart failure than those in urban areas. Rural-dwelling Black men face the greatest risk, with a 34% increased risk compared to urban counterparts.
A large observational study found that heart failure risk is 19% higher for adults living in rural areas of the US compared to urban areas, with a significant disparity in Black men. The study highlights race- and sex-based inequities in heart failure risk, emphasizing the need for targeted interventions to prevent heart failure.
Researchers have discovered an anti-ageing gene that can rewind the heart's biological age by 10 years, offering a potential target for patients with heart failure. The study found that administering the healthy mutant gene to elderly patients with severe heart problems improved their cardiac function and rejuvenated their immune system.
A large clinical trial supported by the National Institutes of Health found that two widely used diuretics, furosemide and torsemide, did not differ in improving patient survival when compared. The study suggests a need for better treatments for heart failure patients and highlights the importance of optimizing diuretic doses to improv...
Researchers found that patients with low comorbidity groups who received more frequent phone calls had improved outcomes, including reduced mortality and longer hospital stays. The intervention involved regular calls from nurses to monitor patient response and address any unusual symptoms.
A recent study found that patients treated at centers that don't perform transplants have a 79% higher odds of being denied bridge-to-transplant designation. This change could exacerbate existing disparities in access to heart transplantation, according to the research team.